MYH9 recruited by Thy28 to the <i>Pax5</i> 1A promoter region induces Pax5 expression. by Toshitsugu Fujita (25023)

“…<b>(B)</b> Interaction of MYH9 with the <i>Pax5</i> 1A promoter region. DT40 cell lines, shGFP#1, shThy28-Seq3#2, shThy28(+)3xFL-cThy28#2, established in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116579#pone.0116579.g006" target="_blank">Fig. 6</a> were used for ChIP assay with an anti-MYH9 Ab (mean +/− SEM, n = 3). …”

The role of actin filaments in recruitment of Rab5-positive endosomes to the large tombusviral replication compartments in plant cells. by Kai Xu (122914)

PRMT5 regulates alternative splicing landscape under hypoxia. by Srinivas Abhishek Mutnuru (22513457)

“…<b>I)</b> qRT-PCR showing a decrease in 18A/18B ratio upon PRMT5 OE in shPRMT5 MCF7 cells under hypoxia. …”

Lack of Nod2 increased number of protective CD4⁺ T cells and decreased frequency of CD8⁺ T cells during severe <i>Ehrlichia</i> infection. by Partho Chattoraj (77532)

Time-dependent changes in total retinal thickness, and mixed cone and rod response in the WT and RP rabbits. by Yuki Muraoka (168112)

“…The total retinal thickness in the WT rabbits (indicated with a blue line) was unchanged during observation, whereas that in the RP rabbits (indicated with a red line) severely decreased with age. …”

Front-of-pack nutritional labels: Understanding by low- and middle-income Mexican consumers by Jorge Vargas-Meza (7878926)

“…<div><p>Front-of-pack labeling is a cost-effective strategy to decrease population consumption of sodium, sugar, saturated fat, total fat, and trans-fatty acids, considered critical nutrients for chronic disease. …”

Simulations that now also include an <i>asymmetric</i> indoors/outdoors model, with a threshold temperature of 17.5C in spring, and 25C in fall. by Sebastian A. Müller (10688740)

A scheme of the proposed model and of its encoding/decoding of the visual information. by Guido Maiello (811194)

A Dissolved Oxygen Threshold for Shifts in Bacterial Community Structure in a Seasonally Hypoxic Estuary by Rachel L. Spietz (782905)

“…Bacterial community composition across all samples was also strongly associated with the dissolved oxygen gradient, and significant changes in bacterial community composition occurred at a dissolved oxygen concentration between 5.18 and 7.12 mg O₂ L^-1. …”

Patient characteristics and treatment history (N = 33, all TNBCs^†). by Ting-Fang He (5210948)

FOPL utilized in phase I and phase II. by Jorge Vargas-Meza (7878926)

Optimized parameters for mesopic and photopic condition used in the study. by C. Vijay Reena Durai (14498259)

Subjects:

Acupoints were applied in the trial. by Zheng Sun (261083)

Subjects:

Schedule for treatment and outcome assessments. by Zheng Sun (261083)

Subjects:

Vanadium(V^IV)–Porphyrin-Based Metal–Organic Frameworks for Synergistic Bimetallic Activation of Inert C(sp³)–H Bonds by Yefei Wang (430888)

“…Herein, by decorating vanadium­(V^IV)–porphyrin into metal–organic frameworks (MOFs) to stabilize the active tertbutyl peroxide radical, we reported a new approach to accomplish inert C­(sp³)–H bond activation by a synergistic bimetallic strategy via a hydrogen atom transfer process under mild conditions. …”

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis by Ting-Fang He (5210948)

“…Immune profiles of TNBCs in a cohort of “good outcome” (no relapse within 5 years) patients were also analyzed. …”

Cumulative incidence of SARS-CoV-2 infection from April 30th, 2020 through April 30th, 2021 among SARS-CoV-2 index positive vs SARS-CoV-2 index negative individuals. by Shannon L. Reynolds (14822662)

Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”

Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”

Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”